Loading organizations...
Loading organizations...
Hand-held PCR test device for rapid infectious disease diagnosis.
Nuclein has raised $14.0M across 1 funding round.
Nuclein has raised $14.0M in total across 1 funding round.
Nuclein has raised $14.0M in total across 1 funding round.
Nuclein's investors include Trinity Private Equity Group.
Nuclein has raised $14.0M across 1 funding round. Most recently, it raised $14.0M Series B in April 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 2, 2021 | $14.0M Series B | Trinity Private Equity Group |